March 25 (Reuters) - The abortion opponents who are seeking to convince the U.S. Supreme Court to limit access to the abortion pill mifepristone point to three studies by Gynuity Health Projects, a New York-based women's health research group, to back up their arguments that it is unsafe despite its regulatory approval decades ago.
Following similar campaigns mounted by industry players and biopharma trade groups, the United States' Solicitor General has joined a chorus of voices calling on the Supreme Court to overturn an appeals court’s August ruling surrounding the abortion pill mifepristone.
Sept 21 (Reuters) - California on Thursday sued two anti-abortion organizations for telling patients that they can help reverse the effects of the abortion pill mifepristone, a potentially dangerous claim not supported by evidence.
Aug 25 (Reuters) - GenBioPro Inc, which sells a generic version of the abortion pill mifepristone, has lost a bid to overturn West Virginia's near-total ban on abortion.
The US Department of Justice is heading to the Supreme Court with a challenge to the latest court-imposed restrictions around the abortion drug mifepristone.
The Republican-led House Appropriations Committee on Wednesday advanced the 2024 FDA spending bill by a 34-27 vote after Democrats failed to remove language in the bill that would nullify changes the FDA made to the risk evaluation and mitigation strategy (REMS) for the abortion pill mifepristone in January.
(Reuters) - Lawyers for abortion pill maker GenBioPro Inc on Tuesday urged a West Virginia federal judge to allow them to proceed with their challenge to the state's near-total abortion ban, claiming it is invalid because it interferes with the federal government's approval of mifepristone.
NEW ORLEANS (WVUE) - A federal appeals court in New Orleans held a two-hour hearing on Wednesday on an abortion pill pro-life forces say is dangerous and the FDA says is safe.
May 17 (Reuters) - Federal appeals court judges on Wednesday appeared to express support for opponents of the abortion pill mifepristone to pursue their challenge to its U.S. approval, which has potentially far-reaching consequences for abortion access across the country.
BUENOS AIRES, May 16 (Reuters) - When Argentine trainee nursery teacher Lourdes, 24, went to the doctor in March seeking to end her pregnancy she was one of the first in the country to be prescribed abortion pill mifepristone after local regulators had approved it fully just weeks earlier.